1
Participants
Start Date
September 30, 2008
Primary Completion Date
June 30, 2009
Study Completion Date
August 31, 2009
Prolarix (tretazicar co-administered with caricotamide)
Prolarix (26.6 mg/m2 tretazicar co-administered with 200 mg/m2 caricotamide) administered intravenously every 21 days until disease progression
Cliniques Universitaires Saint-Luc, Brussels
Lead Sponsor
BTG International Inc.
OTHER